Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pinakin Davey

Optometrist Pomona, CA Doctor of Optometry

NPI 1659685733 CMS profile 1065377

795 E 2Nd St, Suite 2, Pomona, CA 91766

Open in the dashboard

General payments

$242,955

281 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pinakin Davey of Pomona, CA is reported in the CMS Open Payments database as having received $242,955 across 281 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,868 49
2024 General $8,381 23
2023 General $47,277 65
2022 General $23,018 40
2021 General $12,565 11
2020 General $23,529 18
2019 General $85,318 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pinakin Davey
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Pinakin Davey were reported at $42,868. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Pinakin Davey Optometrist median Middle half National median
2019 $85,318 $159 $67–$371 $163
2020 $23,529 $72 $29–$165 $114
2021 $12,565 $125 $46–$292 $132
2022 $23,018 $162 $66–$374 $149
2023 $47,277 $177 $72–$406 $160
2024 $8,381 $188 $77–$427 $164
2025 $42,868 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $143,656 169 payments
  2. Haag-Streit USA, Inc. $31,691 9 payments
  3. Optovue, Inc. $28,937 14 payments
  4. Reliance Medical Products, Inc. $26,091 7 payments
  5. Thea Pharma Inc. $3,861 14 payments
  6. Bausch & Lomb, a division of Bausch Health US, LLC $2,032 13 payments
  7. Allergan Inc. $1,908 5 payments
  8. Tarsus Pharmaceuticals, Inc. $1,293 5 payments
  9. Bausch & Lomb Americas Inc. $1,079 7 payments
  10. Aerie Pharmaceuticals, Inc. $675 3 payments
  11. Other $1,733 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100,569 38 payments
  2. Consulting Fee $80,361 27 payments
  3. Travel and Lodging $40,248 84 payments
  4. Honoraria $13,910 7 payments
  5. Food and Beverage $7,317 122 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $350 1 payment
  7. Education $200 2 payments
Products named General payments · program years 2019–2025
  1. FABRAZYME Genetic Disease $42,048 41 payments
  2. FABRAZYME Rare Disease Genetics $24,379 34 payments
  3. iVue $18,000 4 payments
  4. iFusion $9,160 4 payments
  5. IYUZEH $3,511 11 payments
  6. ALDURAZYME $2,759 6 payments
  7. CEREZYME $2,759 6 payments
  8. LUMIZYME $2,759 6 payments
  9. CERDELGA $2,759 6 payments
  10. VYZULTA $1,778 8 payments
  11. Other $8,659 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

281 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record